XML 36 R28.htm IDEA: XBRL DOCUMENT
v3.25.3

Loss per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Net Loss Per Share of Common Stock | The following table sets forth the computation of basic and diluted net loss per share of common stock for the periods indicated, in thousands except share and per share data:
| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Basic and diluted net loss per common share calculation: |  |  |  |  |  |  |  |  |  |  |
Net loss | $ | (4,423 | ) |  | $ | (2,874 | ) |  | $ | (16,673 | ) |  | $ | (9,075 | )
Change in fair value of derivative instruments |  | — |  |  |  | — |  |  |  | — |  |  |  | (5,047 | )
Net loss attributable to common stockholders – basic |  | (4,423 | ) |  |  | (2,874 | ) |  |  | (16,673 | ) |  |  | (14,122 | )
Weighted average common stock outstanding – basic |  | 107,428,969 |  |  |  | 7,855,763 |  |  |  | 57,845,406 |  |  |  | 6,232,123 |
Net loss per share of common stock – basic | $ | (0.04 | ) |  | $ | (0.37 | ) |  | $ | (0.29 | ) |  | $ | (1.46 | )
Weighted average common stock outstanding - diluted |  | 107,428,969 |  |  |  | 7,855,763 |  |  |  | 57,845,406 |  |  |  | 8,452,338 |
Net loss per share of common stock - diluted | $ | (0.04 | ) |  | $ | (0.37 | ) |  | $ | (0.29 | ) |  | $ | (1.67 | )
Schedule of Antidilutive Securities Excluded from Diluted Loss per Share | The following table provides a summary of instruments where underlying shares issuable upon exercise or conversion were excluded from the diluted loss per share calculation for the periods presented because their effect would be anti-dilutive. Additionally, the shares underlying the February 2025 Warrants, Funding Notes and Exchange Notes, each outstanding during the nine months ended September 30, 2025, were excluded from diluted loss per share as their effect would be anti-dilutive.
| As of September 30, |
| 2025 |  |  | 2024 |
Outstanding stock options |  |  | 11,272,863 |  |  |  | 598,540 |
Outstanding restricted stock units |  |  | 2,823,857 |  |  |  | - |
Preferred stock |  |  | 28,190 |  |  |  | 28,190 |
Outstanding warrants (Note 13) |  |  | 3,141,993 |  |  |  | 706,674 |
Total |  |  | 17,266,903 |  |  |  | 1,333,404 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration